DTILPRECISION BIOSCIENCES INC
- Market cap
- $183.27M
- as of 2026-10-23
- Latest close
- $6.64
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
3 insiders bought $29.5K between Sep 25 – Sep 28.
Under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-27
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Frankel Stanley | Sep 28 | Sep 30 | P | 1,000 | $6.00 | Purchase +$6,000 | 41,478 | No | Form 4 |
| Germano Geno J | Sep 25 | Sep 29 | P | 2,609 | $6.28 | Purchase +$16,385 | 47,492 | No | Form 4 |
| Brown Melinda | Sep 25 | Sep 29 | P | 1,135 | $6.27 | Purchase +$7,116 | 45,481 | No | Form 4 |
| Buehler Kevin | Jun 3 | Jun 5 | A · derivative | 20,979 | $0.00 | $0 | 20,979 | No | Form 4 |
| Pire Shari Lisa | Jun 3 | Jun 5 | A · derivative | 20,979 | $0.00 | $0 | 20,979 | No | Form 4 |
| Germano Geno J | Jun 3 | Jun 5 | A · derivative | 20,979 | $0.00 | $0 | 20,979 | No | Form 4 |
| Frankel Stanley | Jun 3 | Jun 5 | A · derivative | 20,979 | $0.00 | $0 | 20,979 | No | Form 4 |
| Brown Melinda | Jun 3 | Jun 5 | A · derivative | 20,979 | $0.00 | $0 | 20,979 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Jun 1 | Jun 3 | A · derivative | 573,888 | $0.00 | $0 | 573,888 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jun 1 | Jun 3 | A · derivative | 193,688 | $0.00 | $0 | 193,688 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jun 1 | Jun 3 | A · derivative | 107,604 | $0.00 | $0 | 107,604 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Jun 1 | Jun 3 | A · derivative | 57,389 | $0.00 | $0 | 57,389 | No | Form 4 |
| Germano Geno J | May 20 | May 22 | M | 21,000 | not reported | not reported | 44,883 | No | Form 4 |
| Germano Geno J | May 20 | May 22 | M · derivative | 21,000 | $0.00 | $0 | not reported | No | Form 4 |
| Pire Shari Lisa | May 20 | May 22 | M | 21,000 | not reported | not reported | 35,028 | No | Form 4 |
| Pire Shari Lisa | May 20 | May 22 | M · derivative | 21,000 | $0.00 | $0 | not reported | No | Form 4 |
| Brown Melinda | May 20 | May 22 | M | 21,000 | not reported | not reported | 44,346 | No | Form 4 |
| Brown Melinda | May 20 | May 22 | M · derivative | 21,000 | $0.00 | $0 | not reported | No | Form 4 |
| Frankel Stanley | May 20 | May 22 | M | 21,000 | not reported | not reported | 40,478 | No | Form 4 |
| Frankel Stanley | May 20 | May 22 | M · derivative | 21,000 | $0.00 | $0 | not reported | No | Form 4 |
| Buehler Kevin | May 20 | May 22 | M | 21,000 | not reported | not reported | 49,137 | No | Form 4 |
| Buehler Kevin | May 20 | May 22 | M · derivative | 21,000 | $0.00 | $0 | not reported | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Feb 18 | Feb 19 | S | 4,925 | $3.84 | Sale −$18,912 | 121,926 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Feb 18 | Feb 19 | S | 4,925 | $3.84 | Sale −$18,912 | 56,457 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Feb 18 | Feb 19 | S | 8,149 | $3.84 | Sale −$31,292 | 125,883 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Feb 18 | Feb 19 | S | 20,559 | $3.84 | Sale −$78,947 | 243,392 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Feb 17 | Feb 19 | M | 16,667 | $0.00 | $0 | 126,851 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Feb 17 | Feb 19 | M · derivative | 16,667 | $0.00 | $0 | 33,333 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Feb 17 | Feb 19 | M | 16,667 | $0.00 | $0 | 61,382 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Feb 17 | Feb 19 | M · derivative | 16,667 | $0.00 | $0 | 33,333 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Feb 17 | Feb 19 | M | 27,584 | $0.00 | $0 | 134,032 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Feb 17 | Feb 19 | M · derivative | 27,584 | $0.00 | $0 | 55,166 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Feb 17 | Feb 19 | M | 67,797 | $0.00 | $0 | 263,951 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Feb 17 | Feb 19 | M · derivative | 67,797 | $0.00 | $0 | 135,593 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 22 | Jan 22 | S | 34,799 | $4.17 | Sale −$145,112 | 196,154 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 21 | Jan 22 | M | 16,219 | not reported | not reported | 120,384 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 21 | Jan 22 | S | 10,200 | $4.03 | Sale −$41,106 | 110,184 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 21 | Jan 22 | S | 15,213 | $4.03 | Sale −$61,308 | 106,448 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 21 | Jan 22 | S | 8,854 | $4.03 | Sale −$35,682 | 44,715 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20 | Jan 22 | M | 2,500 | not reported | not reported | 93,718 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20 | Jan 22 | M | 10,447 | not reported | not reported | 104,165 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20 | Jan 22 | M · derivative | 2,500 | $0.00 | $0 | not reported | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20 | Jan 22 | M · derivative | 10,447 | $0.00 | $0 | 10,447 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20 | Jan 22 | M · derivative | 16,219 | $0.00 | $0 | 16,219 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20 | Jan 22 | M | 3,888 | not reported | not reported | 81,186 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20 | Jan 22 | M | 13,900 | not reported | not reported | 95,086 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20 | Jan 22 | M | 26,575 | not reported | not reported | 121,661 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20 | Jan 22 | M · derivative | 3,888 | $0.00 | $0 | not reported | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20 | Jan 22 | M · derivative | 13,900 | $0.00 | $0 | 13,901 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20 | Jan 22 | M · derivative | 26,575 | $0.00 | $0 | 26,575 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20 | Jan 22 | M | 1,978 | $0.00 | $0 | 30,236 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20 | Jan 22 | M | 8,425 | $0.00 | $0 | 38,661 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20 | Jan 22 | M | 14,908 | $0.00 | $0 | 53,569 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20 | Jan 22 | M · derivative | 1,978 | $0.00 | $0 | not reported | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20 | Jan 22 | M · derivative | 8,425 | $0.00 | $0 | 8,425 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20 | Jan 22 | M · derivative | 14,908 | $0.00 | $0 | 14,907 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20 | Jan 22 | M | 8,888 | not reported | not reported | 124,463 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20 | Jan 22 | M | 37,069 | not reported | not reported | 161,532 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20 | Jan 22 | M | 69,421 | not reported | not reported | 230,953 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20 | Jan 22 | M · derivative | 8,888 | $0.00 | $0 | not reported | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20 | Jan 22 | M · derivative | 37,069 | $0.00 | $0 | 37,069 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20 | Jan 22 | M · derivative | 69,421 | $0.00 | $0 | 69,421 | Yes | Form 4 |
| Frankel Stanley | Dec 16, 2025 | Dec 17, 2025 | P | 2,700 | $4.70 | Purchase +$12,690 | 19,478 | No | Form 4 |
| Germano Geno J | Dec 16, 2025 | Dec 17, 2025 | P | 3,000 | $4.72 | Purchase +$14,160 | 23,883 | No | Form 4 |
| Brown Melinda | Dec 15, 2025 | Dec 17, 2025 | P | 1,381 | $4.97 | Purchase +$6,864 | 23,346 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 3, 2025 | Nov 4, 2025 | S | 3,409 | $6.49 | Sale −$22,124 | 115,575 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 3, 2025 | Nov 4, 2025 | M · derivative | 9,444 | $0.00 | $0 | not reported | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 3, 2025 | Nov 4, 2025 | S | 665 | $6.49 | Sale −$4,316 | 28,258 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 3, 2025 | Nov 4, 2025 | S | 1,303 | $6.49 | Sale −$8,456 | 77,298 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 2, 2025 | Nov 4, 2025 | M | 9,444 | $0.00 | $0 | 118,984 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 2, 2025 | Nov 4, 2025 | M | 1,835 | $0.00 | $0 | 28,923 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 2, 2025 | Nov 4, 2025 | M · derivative | 1,835 | $0.00 | $0 | not reported | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 2, 2025 | Nov 4, 2025 | M | 3,605 | $0.00 | $0 | 78,601 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 2, 2025 | Nov 4, 2025 | M · derivative | 3,605 | $0.00 | $0 | not reported | Yes | Form 4 |
| Frankel Stanley | Sep 26, 2025 | Sep 30, 2025 | P | 2,700 | $4.97 | Purchase +$13,419 | 16,778 | No | Form 4 |
| Brown Melinda | Sep 22, 2025 | Sep 24, 2025 | P | 1,400 | $4.89 | Purchase +$6,846 | 21,965 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jul 3, 2025 | Jul 8, 2025 | S | 14,827 | $4.26 | Sale −$63,163 | 73,485 | Yes | Form 4 |
| Buehler Kevin | Jun 25, 2025 | Jun 27, 2025 | P | 5,076 | $4.16 | Purchase +$21,116 | 28,137 | No | Form 4 |
| Brown Melinda | Jun 25, 2025 | Jun 27, 2025 | P | 1,682 | $4.14 | Purchase +$6,963 | 20,565 | No | Form 4 |
| Brown Melinda | Jun 3, 2025 | Jun 4, 2025 | A · derivative | 21,000 | $0.00 | $0 | 21,000 | No | Form 4 |
| Buehler Kevin | Jun 3, 2025 | Jun 4, 2025 | A · derivative | 21,000 | $0.00 | $0 | 21,000 | No | Form 4 |
| Frankel Stanley | Jun 3, 2025 | Jun 4, 2025 | A · derivative | 21,000 | $0.00 | $0 | 21,000 | No | Form 4 |
| Pire Shari Lisa | Jun 3, 2025 | Jun 4, 2025 | A · derivative | 21,000 | $0.00 | $0 | 21,000 | No | Form 4 |
| Germano Geno J | Jun 3, 2025 | Jun 4, 2025 | A · derivative | 21,000 | $0.00 | $0 | 21,000 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jun 2, 2025 | Jun 4, 2025 | A · derivative | 82,750 | $0.00 | $0 | 82,750 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Jun 2, 2025 | Jun 4, 2025 | A · derivative | 203,390 | $0.00 | $0 | 203,390 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jun 2, 2025 | Jun 4, 2025 | A · derivative | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Jun 2, 2025 | Jun 4, 2025 | A · derivative | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Brown Melinda | May 27, 2025 | Jun 4, 2025 | M | 9,826 | not reported | not reported | 18,883 | No | Form 4 |
| Brown Melinda | May 27, 2025 | Jun 4, 2025 | M · derivative | 9,826 | $0.00 | $0 | not reported | No | Form 4 |
| Buehler Kevin | May 27, 2025 | Jun 4, 2025 | M | 9,826 | not reported | not reported | 23,061 | No | Form 4 |
| Buehler Kevin | May 27, 2025 | Jun 4, 2025 | M · derivative | 9,826 | $0.00 | $0 | not reported | No | Form 4 |
| Frankel Stanley | May 27, 2025 | Jun 4, 2025 | M | 9,826 | not reported | not reported | 14,078 | No | Form 4 |
| Frankel Stanley | May 27, 2025 | Jun 4, 2025 | M · derivative | 9,826 | $0.00 | $0 | not reported | No | Form 4 |
| Pire Shari Lisa | May 27, 2025 | Jun 4, 2025 | M | 9,826 | not reported | not reported | 14,028 | No | Form 4 |
| Pire Shari Lisa | May 27, 2025 | Jun 4, 2025 | M · derivative | 9,826 | $0.00 | $0 | not reported | No | Form 4 |
| Germano Geno J | May 27, 2025 | Jun 4, 2025 | M | 9,826 | not reported | not reported | 20,883 | No | Form 4 |
| Germano Geno J | May 27, 2025 | Jun 4, 2025 | M · derivative | 9,826 | $0.00 | $0 | not reported | No | Form 4 |
| Buehler Kevin | Mar 26, 2025 | Mar 28, 2025 | P | 4,523 | $4.67 | Purchase +$21,122 | 13,235 | No | Form 4 |
| Brown Melinda | Mar 26, 2025 | Mar 28, 2025 | P | 1,839 | $4.75 | Purchase +$8,735 | 9,057 | No | Form 4 |
| Germano Geno J | Mar 25, 2025 | Mar 27, 2025 | P | 3,250 | $5.30 | Purchase +$17,225 | 11,057 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Mar 24, 2025 | Mar 25, 2025 | S | 964 | $5.56 | Sale −$5,360 | 109,540 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Mar 21, 2025 | Mar 25, 2025 | M | 3,417 | not reported | not reported | 110,504 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Mar 21, 2025 | Mar 25, 2025 | M · derivative | 3,417 | $0.00 | $0 | not reported | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Mar 4, 2025 | Mar 5, 2025 | S | 154 | $4.91 | Sale −$756 | 87,805 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Mar 4, 2025 | Mar 5, 2025 | S | 272 | $4.91 | Sale −$1,336 | 25,000 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Mar 3, 2025 | Mar 5, 2025 | M | 1,702 | not reported | not reported | 86,256 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Mar 3, 2025 | Mar 5, 2025 | M · derivative | 1,702 | $0.00 | $0 | not reported | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Mar 3, 2025 | Mar 5, 2025 | M | 519 | not reported | not reported | 87,959 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Mar 3, 2025 | Mar 5, 2025 | M · derivative | 519 | $0.00 | $0 | not reported | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Mar 3, 2025 | Mar 5, 2025 | M | 919 | not reported | not reported | 25,272 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Mar 3, 2025 | Mar 5, 2025 | M · derivative | 919 | $0.00 | $0 | not reported | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 22, 2025 | Jan 22, 2025 | S | 10,287 | $4.79 | Sale −$49,275 | 87,440 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 22, 2025 | Jan 22, 2025 | S | 8,928 | $4.79 | Sale −$42,765 | 24,353 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 21, 2025 | Jan 22, 2025 | S | 36,838 | $4.67 | Sale −$172,033 | 107,087 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20, 2025 | Jan 22, 2025 | M | 29,168 | not reported | not reported | 97,727 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 2,500 | $0.00 | $0 | 2,500 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 10,449 | $0.00 | $0 | 20,894 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 16,219 | $0.00 | $0 | 32,438 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20, 2025 | Jan 22, 2025 | M | 44,368 | not reported | not reported | 84,554 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 3,889 | $0.00 | $0 | 3,888 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 13,904 | $0.00 | $0 | 27,801 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 26,575 | $0.00 | $0 | 53,150 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20, 2025 | Jan 22, 2025 | M | 115,388 | not reported | not reported | 143,925 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 8,888 | $0.00 | $0 | 8,888 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 37,079 | $0.00 | $0 | 74,138 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 69,421 | $0.00 | $0 | 138,842 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20, 2025 | Jan 22, 2025 | M | 25,312 | not reported | not reported | 33,281 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 1,977 | $0.00 | $0 | 1,978 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 8,427 | $0.00 | $0 | 16,850 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20, 2025 | Jan 22, 2025 | M · derivative | 14,908 | $0.00 | $0 | 29,815 | Yes | Form 4 |
| Germano Geno J | Dec 30, 2024 | Jan 2, 2025 | P | 3,605 | $4.49 | Purchase +$16,186 | 7,807 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Dec 27, 2024 | Dec 31, 2024 | P | 2,113 | $4.75 | Purchase +$10,037 | 40,186 | No | Form 4 |
| Buehler Kevin | Dec 27, 2024 | Dec 31, 2024 | P | 4,320 | $4.88 | Purchase +$21,082 | 8,712 | No | Form 4 |
| Brown Melinda | Dec 26, 2024 | Dec 30, 2024 | P | 3,016 | $4.55 | Purchase +$13,723 | 7,218 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 21, 2024 | Nov 21, 2024 | P | 3,000 | $6.76 | Purchase +$20,280 | 38,073 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 4, 2024 | Nov 5, 2024 | S | 3,012 | $8.19 | Sale −$24,668 | 28,537 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 4, 2024 | Nov 5, 2024 | S | 588 | $8.19 | Sale −$4,816 | 7,969 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 2, 2024 | Nov 5, 2024 | M | 9,443 | not reported | not reported | 31,549 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 2, 2024 | Nov 5, 2024 | M · derivative | 9,443 | $0.00 | $0 | 9,444 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 2, 2024 | Nov 5, 2024 | M | 1,836 | $0.00 | $0 | 8,557 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 2, 2024 | Nov 5, 2024 | M · derivative | 1,836 | $0.00 | $0 | 1,835 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 2, 2024 | Nov 5, 2024 | M | 3,605 | not reported | not reported | 35,073 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 2, 2024 | Nov 5, 2024 | M · derivative | 3,605 | $0.00 | $0 | 3,605 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Aug 22, 2024 | Aug 23, 2024 | A · derivative | 44,723 | $0.00 | $0 | 44,723 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Aug 22, 2024 | Aug 23, 2024 | A · derivative | 208,263 | $0.00 | $0 | 208,263 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Aug 22, 2024 | Aug 23, 2024 | A · derivative | 79,725 | $0.00 | $0 | 79,725 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Aug 22, 2024 | Aug 23, 2024 | A · derivative | 48,657 | $0.00 | $0 | 48,657 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Jun 10, 2024 | Jun 11, 2024 | S | 50 | $11.79 | Sale −$590 | 68,559 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jun 10, 2024 | Jun 11, 2024 | S | 93 | $11.79 | Sale −$1,096 | 6,721 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jun 7, 2024 | Jun 11, 2024 | M | 163 | not reported | not reported | 68,609 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Jun 7, 2024 | Jun 11, 2024 | M · derivative | 163 | $0.00 | $0 | not reported | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jun 7, 2024 | Jun 11, 2024 | M | 454 | not reported | not reported | 31,468 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jun 7, 2024 | Jun 11, 2024 | M · derivative | 454 | $0.00 | $0 | not reported | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jun 7, 2024 | Jun 11, 2024 | M | 301 | $0.00 | $0 | 6,814 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jun 7, 2024 | Jun 11, 2024 | M · derivative | 301 | $0.00 | $0 | not reported | Yes | Form 4 |
| Wadsworth Samuel C. | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 9,826 | $0.00 | $0 | 9,826 | No | Form 4 |
| Pire Shari Lisa | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 9,826 | $0.00 | $0 | 9,826 | No | Form 4 |
| Germano Geno J | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 9,826 | $0.00 | $0 | 9,826 | No | Form 4 |
| Frankel Stanley | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 9,826 | $0.00 | $0 | 9,826 | No | Form 4 |
| Buehler Kevin | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 9,826 | $0.00 | $0 | 9,826 | No | Form 4 |
| Brown Melinda | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 9,826 | $0.00 | $0 | 9,826 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | May 8, 2024 | May 8, 2024 | A | 833 | $12.00 | $9,996 | 6,513 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | May 8, 2024 | May 8, 2024 | A | 833 | $12.00 | $9,996 | 68,446 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | May 8, 2024 | May 8, 2024 | A | 8,334 | $12.00 | $100,008 | 31,014 | No | Form 4 |
| Amoroso MichaelPresident and CEO | May 8, 2024 | May 8, 2024 | A | 8,334 | $12.00 | $100,008 | 22,106 | No | Form 4 |
| Brown Melinda | May 4, 2024 | May 7, 2024 | M | 4,202 | not reported | not reported | 4,202 | No | Form 4 |
| Brown Melinda | May 4, 2024 | May 7, 2024 | M · derivative | 4,202 | $0.00 | $0 | not reported | No | Form 4 |
| Frankel Stanley | May 4, 2024 | May 7, 2024 | M | 4,202 | not reported | not reported | 4,252 | No | Form 4 |
| Frankel Stanley | May 4, 2024 | May 7, 2024 | M · derivative | 4,202 | $0.00 | $0 | not reported | No | Form 4 |
| Germano Geno J | May 4, 2024 | May 7, 2024 | M | 4,202 | not reported | not reported | 4,202 | No | Form 4 |
| Germano Geno J | May 4, 2024 | May 7, 2024 | M · derivative | 4,202 | $0.00 | $0 | not reported | No | Form 4 |
| Wadsworth Samuel C. | May 4, 2024 | May 7, 2024 | M | 4,202 | not reported | not reported | 4,202 | No | Form 4 |
| Wadsworth Samuel C. | May 4, 2024 | May 7, 2024 | M · derivative | 4,202 | $0.00 | $0 | not reported | No | Form 4 |
| Buehler Kevin | May 4, 2024 | May 7, 2024 | M | 4,202 | not reported | not reported | 4,392 | No | Form 4 |
| Buehler Kevin | May 4, 2024 | May 7, 2024 | M · derivative | 4,202 | $0.00 | $0 | not reported | No | Form 4 |
| Pire Shari Lisa | May 4, 2024 | May 7, 2024 | M | 4,202 | not reported | not reported | 4,202 | No | Form 4 |
| Pire Shari Lisa | May 4, 2024 | May 7, 2024 | M · derivative | 4,202 | $0.00 | $0 | not reported | No | Form 4 |
| Amoroso MichaelPresident and CEO | May 2, 2024 | May 3, 2024 | S | 1,526 | $10.32 | Sale −$15,748 | 13,772 | No | Form 4 |
| List AlanChief Medical Officer | May 2, 2024 | May 3, 2024 | S | 290 | $10.32 | Sale −$2,993 | 4,488 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | May 2, 2024 | May 3, 2024 | S | 154 | $10.32 | Sale −$1,589 | 67,613 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | May 2, 2024 | May 3, 2024 | S | 272 | $10.32 | Sale −$2,807 | 5,680 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | May 1, 2024 | May 3, 2024 | M | 3,417 | not reported | not reported | 15,298 | No | Form 4 |
| Amoroso MichaelPresident and CEO | May 1, 2024 | May 3, 2024 | M · derivative | 3,417 | $0.00 | $0 | 3,417 | No | Form 4 |
| List AlanChief Medical Officer | May 1, 2024 | May 3, 2024 | M | 982 | not reported | not reported | 4,778 | No | Form 4 |
| List AlanChief Medical Officer | May 1, 2024 | May 3, 2024 | M · derivative | 982 | $0.00 | $0 | 981 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | May 1, 2024 | May 3, 2024 | M | 519 | not reported | not reported | 67,767 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | May 1, 2024 | May 3, 2024 | M · derivative | 519 | $0.00 | $0 | 519 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | May 1, 2024 | May 3, 2024 | M | 918 | not reported | not reported | 5,952 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | May 1, 2024 | May 3, 2024 | S · derivative | 918 | $0.00 | Sale −$0 | 919 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | May 1, 2024 | May 3, 2024 | M | 1,702 | not reported | not reported | 22,680 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | May 1, 2024 | May 3, 2024 | M · derivative | 1,702 | $0.00 | $0 | 1,702 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Feb 29, 2024 | May 3, 2024 | A | 1,006 | $12.42 | $12,495 | 67,248 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Feb 29, 2024 | May 3, 2024 | A | 506 | $18.50 | $9,361 | 20,978 | No | Form 4 |
| List AlanChief Medical Officer | Apr 30, 2024 | Apr 30, 2024 | S | 238 | $10.03 | Sale −$2,387 | 3,796 | No | Form 4 |
| List AlanChief Medical Officer | Apr 26, 2024 | Apr 30, 2024 | M | 868 | not reported | not reported | 4,034 | No | Form 4 |
| List AlanChief Medical Officer | Apr 26, 2024 | Apr 30, 2024 | M · derivative | 868 | $0.00 | $0 | not reported | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Apr 18, 2024 | Apr 22, 2024 | A · derivative | 41,705 | $0.00 | $0 | 41,705 | No | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Apr 18, 2024 | Apr 22, 2024 | A · derivative | 25,277 | $0.00 | $0 | 25,277 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Apr 18, 2024 | Apr 22, 2024 | A · derivative | 111,217 | $0.00 | $0 | 111,217 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Apr 18, 2024 | Apr 22, 2024 | A · derivative | 31,343 | $0.00 | $0 | 31,343 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 23, 2024 | Jan 23, 2024 | S | 28,000 | $0.37 | Sale −$10,360 | 1,987,269 | No | Form 4 |
| List AlanChief Medical Officer | Jan 22, 2024 | Jan 23, 2024 | S | 21,526 | $0.36 | Sale −$7,749 | 94,982 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 22, 2024 | Jan 23, 2024 | S | 21,287 | $0.36 | Sale −$7,663 | 151,028 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 22, 2024 | Jan 23, 2024 | S | 137,390 | $0.36 | Sale −$49,460 | 356,433 | Yes | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20, 2024 | Jan 23, 2024 | M | 75,015 | not reported | not reported | 2,015,269 | No | Form 4 |
| Smith J. JeffersonChief Research Officer | Jan 20, 2024 | Jan 23, 2024 | M · derivative | 75,015 | $0.00 | $0 | 149,985 | No | Form 4 |
| List AlanChief Medical Officer | Jan 20, 2024 | Jan 23, 2024 | M | 60,012 | not reported | not reported | 116,508 | Yes | Form 4 |
| List AlanChief Medical Officer | Jan 20, 2024 | Jan 23, 2024 | M · derivative | 60,012 | $0.00 | $0 | 119,988 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20, 2024 | Jan 23, 2024 | M | 59,345 | not reported | not reported | 172,315 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Jan 20, 2024 | Jan 23, 2024 | M · derivative | 59,345 | $0.00 | $0 | 118,655 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20, 2024 | Jan 23, 2024 | M | 266,720 | not reported | not reported | 493,823 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Jan 20, 2024 | Jan 23, 2024 | M · derivative | 266,720 | $0.00 | $0 | 533,280 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20, 2024 | Jan 23, 2024 | M | 116,690 | not reported | not reported | 614,169 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Jan 20, 2024 | Jan 23, 2024 | M · derivative | 116,690 | $0.00 | $0 | 233,310 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 3, 2023 | Nov 6, 2023 | S | 125,025 | $0.40 | Sale −$50,010 | 227,103 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 3, 2023 | Nov 6, 2023 | S | 16,023 | $0.40 | Sale −$6,409 | 112,970 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 2, 2023 | Nov 6, 2023 | M | 108,188 | not reported | not reported | 497,479 | No | Form 4 |
| Kelly John AlexanderChief Financial Officer | Nov 2, 2023 | Nov 6, 2023 | M · derivative | 108,188 | $0.00 | $0 | 216,312 | No | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 2, 2023 | Nov 6, 2023 | M | 283,390 | not reported | not reported | 352,128 | Yes | Form 4 |
| Amoroso MichaelPresident and CEO | Nov 2, 2023 | Nov 6, 2023 | M · derivative | 283,390 | $0.00 | $0 | 566,610 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 2, 2023 | Nov 6, 2023 | M | 55,077 | not reported | not reported | 128,993 | Yes | Form 4 |
| Scimeca DarioGeneral Counsel and Secretary | Nov 2, 2023 | Nov 6, 2023 | M · derivative | 55,077 | $0.00 | $0 | 110,123 | Yes | Form 4 |
| Kelly John AlexanderChief Financial Officer | Aug 18, 2023 | Oct 27, 20234/A | P | 90,000 | $0.48 | Purchase +$43,200 | 383,340 | No | Form 4/A |